Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates
Granules India Ltd Q2FY24; 30% fall in Profits
Categories
pharmaceuticals
Glaxosmithkline Pharmaceuticals Ltd Q2FY24; 13% rise in Profits
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd
Bajaj Healthcare Ltd Q4FY23; 79% fall in Profits
Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical
Astrazeneca Pharma India Ltd Q2FY24; 58% rise in Profits
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India
Aurobindo Pharma Ltd Q2FY24; 83% rise in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. Financial Results: Aurobindo Pharma
FDC Ltd Q2FY24; 35% rise in Profits
FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in
ERIS Lifesciences Ltd Q2FY24; 3% rise in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
Alembic Ltd Q2FY24; 21% fall in Profits
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the
Gland Pharma Ltd Q2FY24; 8% rise in Profits
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral
Divis Laboratories Ltd Q2FY24; 29% fall in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for
Sun Pharma Advanced Research Company Ltd Q2FY24; 34% fall in Revenue
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. Financial Results: Sun
Pfizer Ltd Q2FY24; 52% fall in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Gufic Biosciences Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Gufic Biosciences Limited (GUFICBIO) Q2 FY24 Earnings Concall New Product Launches and Approvals Launched new products like Dalbavancin and
Punjab Chemicals & Crop Protection Ltd Q2FY24; 13% fall in Revenue
Started in 1975 as Punjab United Pesticides & Chemicals Limited (PUPCL) has now evolved as Punjab Chemicals and Crop Protection Limited (Punjab
Morepen Laboratories Ltd Q2FY24; 31% rise in Profits
Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs),
RPG Life Sciences Ltd Q2FY24; 30% rise in Profits
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in
Glenmark Pharmaceuticals Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q2 FY24 Earnings Concall Financial Results Revenue increased 6.3% YoY to INR35,879 million. India formulation
Wockhardt Ltd Q2FY24; 11% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Jubilant Ingrevia Ltd Q2FY24; 32% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Marksans Pharma Limited Q2 FY24 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q2 FY24 Earnings Concall Financial Performance Revenues grew 17% year-on-year to INR531 crores in Q2
Procter & Gamble Health Ltd Q2FY24; 3% rise in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals